The risk of liver transaminase elevation after MARV/Ang infection compared to MARV/MtE-Mus infection was significantly higher with an adjusted HR of 2.97 for AST elevation (95% CI: 1.27, 6.91) and an adjusted HR of 3.41 for ALT elevation (95% CI: 1.39, 8.37). The gene discussed is GPT; the disease is infection.